Patients
Physicians
Sponsors
Oncologists
About Us
News
ENG
Last updated 23 days ago
Share
Study to Assess Adverse Events, Change in Disease Activity, and How Oral Upadacitinib Moves Through the Body of Pediatric Participants With Moderately to Severely Active Ulcerative Colitis.
110 patients around the world
Available in
Brazil
AbbVie
2
Research sites
110
Patients around the world
This study is for people with
Ulcerative colitis
Moderate/severe ulcerative colitis
Requirements for the patient
To 17 Years
All Gender
Medical requirements
Inclusion criteria
Exclusion criteria
Sites
Hospital Pequeno Príncipe
Recruiting
Consult
View site
Rua Desembargador Motta, 1070 - Água Verde, Curitiba - PR, 80250-060
View site
Consult
Hospital e Maternidade Celso Pierro
Recruiting
Consult
View site
Campinas, 13590-900
View site
Consult
See details
Contact us
Contact us
Sponsor
AbbVie
Conditions
Ulcerative colitis
Moderate/severe ulcerative colitis
Requirements
To 17 Years
All Gender
Unique study ID
clinicaltrials.gov
NCT05782907
About us
Our mission
Our team
Partners
FAQs
Medical news
Latest news
Studies
Interviews
Testimonials
Products
UEPM Onco
UEPM Physicians
Links
Downloads
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent